TrialHaematologica2015

Phase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 trial.

Philippe Rodon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.